Institute of Biophysics and Cell Engineering

http://ibp.org.by/  
220072 Minsk, Akademicheskaya str. 27

Spirulina

COUNTRY OF ORIGIN

IDENTIFIER

BO5672

PUBLISHED

2022-10-07

LAST UPDATE

2022-10-07

DEADLINE

Linked profile in other language
Responsible
Elena Кniazeva
+375 17 251 5357
kniazeva@ibp.org.by
Summary
The Institute offers spirulina biomass to consumers under a manufacturing agreement.
Description
The Institute has developed a technology for the production of spirulina biomass and created a manufacturing area for its production.

Spirulina (Spirulina (Arthrospira) platensis) is a blue-green prokaryotic microalgae.

Spirulina contains:
* up to 70% protein, which consists of 18 amino acids, 8 of which are irreplaceable;
* more than 10 vitamins;
* organic compounds of iodine;
* up to 20 mineral elements (calcium, iron, magnesium, etc.);
* antioxidants, including phycocyanin - one of the most active antioxidants and radioprotectors.

Spirulina restores vitamin and mineral deficiencies, removes heavy metals and radionuclides from the body, normalizes metabolism, lowers cholesterol, has anti-inflammatory and immunomodulatory effects

Spirulina is used in diets for children and diets, for feeding agricultural and domestic animals, as a raw material for the production of medicines, cosmetics, as well as in scientific research.

The institute offers spirulina biomass to consumers under a production agreement.

The price list can be found on the institute's website.
Advantages and Innovations
The produced biomass of spirulina is characterized by a high content of chlorophyll, active biologically active substances and a low content of heavy metals.
Stage of development
Already on the market
Comments regarding stage of development
The site for the production of spirulina biomass has been operating at the institute since 2019.
Funding source
State budged
IPR status
Secret know-how
Sector group
Agrofood
BioChemTech
Environment
Healthcare

Organization information

Year established
1973
NACE keywords
Q.86.90 - Other human health activities
M.72.11 - Research and experimental development on biotechnology
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Additional comments
Over the past 10 years, the Institute has carried out a number of international contracts and agreements within the framework of the Framework Programs of the European Union, as well as with leading research centers, foundations, societies:

FP7-HEALTH-2007-4.1-8 «Promotion and facilitation of international cooperation with Eastern European and Central Asian Countries» (EECAlink, Nr. 223359), 2009-2011;

UNESCO № IAP 3240246593/011/027-Minsk « Science Academies in the Central and Eastern Europe and their Role in Knowledge-based Society», 2010-2011;

FP7-PEAPLE-2012-IRSES «Development of Nanotechnology based Biosensors for Agriculture» (PIRSES-GA-2012-318520), 2012-2016;

FP7-PEAPLE-2012-IRSES «EU-Belarus-Russia Network in Nanomaterials-Driven Anti-Cancer Gene Therapy» (PIRSES-GA-2012-316730), 2013-2017;

FP7-PEOPLE-2011-IIF-299194 «Optical real-time imaging of inhibitory GABAA receptors activity using chimeric GABA channel subunit» («ImagingGABA» Nr 299194) 2013-2015;

«INNOVIMMUNE: Baltic Platform for Innovative Immunotherapies», Nr 19806/2016,2016-2018;

NAWA IAP «Strengthening and spreading international partnership activities of the Faculty of Biology and Environmental Protection for interdisciplinary research and innovation of the University of Lodz» (№ PPI/APM/2018/1/00007/U/001) 2019-2020;

H2020-MSCA-RISE-2017 «Novel 1D photonic metal oxide nanostructures for early stage cancer detection» («CanBioSe», Nr 778157) 2018-2021:

The International Organization for Neurochemistry (ISN); Takeda Science Foundation; The Karpilo-Landau Society; Swiss National Science Foundation; University of Eastern Finland; World Federation of Scientists to Support Research, etc.
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing spirulina biomass under a manufacturing agreement.
Type and size of partner sought
> 500 MNE
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor

Attachments

Views: 870
Statistics since 07.10.2022 23:43:04